We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of MBII yet.

MBII Hedge Fund Activity: Q3 2022 in Review

0 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2022, worth a combined $0 — down 100% from $45M a quarter earlier.

Sellers outnumbered buyers: 62 funds closed out of MBII and 0 opened new positions — a net loss of 62 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ardsley Advisory Partners, exiting entirely with an estimated $21.3M sold.

  • 0 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2022, down from 62 in Q2 2022.
  • Funds reported $0 of Marrone Bio Innovations, Inc. stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2022 and 62 closed out, a net change of -62 holders.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2022 was Ardsley Advisory Partners, an estimated $21.3M sold.

Based on aggregated 13F filings for Q3 2022.